EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Total body irradiation-based conditioning in allogeneic transplantation in patients with hematological malignancies: impact in outcomes by stem-cell source

Uriel Alexander Corro Verde, Jesús Romero Fernández, Beatriz Gil Haro, Marta López Valcárcel, Patricia Sarrión Rubio De la Torre, Guiomar Bautista, Cristina De la Fuente Alonso

Clinical and Translational Oncology · 11.08.2026

DOI: 10.1007/s12094-026-04523-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Oncology, online erschienen am 11.08.2026. Verfasst von Uriel Alexander Corro Verde und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain. Uriel.corro@estudiante.uam.es. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CRUE-CESIC, Universidad Autónoma de Madrid.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Total body irradiation is widely used in conditioning regimens before allogeneic hematopoietic stem-cell transplantation (allo-HSCT), most often in high-risk acute lymphoblastic leukemia. This study assessed survival outcomes and treatment-related toxicity in patients who underwent TBI-based myeloablative conditioning.

Methods

We conducted a retrospective single-center study of patients who underwent allo-HSCT after TBI-based conditioning at a reference TBI-unit serving transplant across the Community of Madrid. Between 2011 and 2020, most patients ( n = 52) received 10 Gy in 2 Gy fractions twice daily. Primary endpoints were overall survival (OS), disease-free survival (DFS), and relapse; secondary endpoints included non-relapse mortality (NRM), disease-related mortality (DRM), and toxicity.

Results

58 patients underwent TBI-based conditioning using peripheral blood stem cells (PBSC; n = 37), umbilical cord blood (UCB; n = 19), or bone marrow (BM; n = 1); one patient died before graft infusion. Diagnoses were B-ALL (79.3%), followed by T-ALL (15.5%), non-Hodgkin lymphoma (3.4%), and acute myeloid leukemia (1.7%). Median follow-up was 28 months. At 12 months, OS, DFS, and relapse were 64%, 48%, and 29%, respectively. PBSC transplantation had significantly higher 12-month OS than UCB (78% vs. 37%, p < 0.001). Six-month NRM was 5% and 8% in PBSC recipients vs. 43% and 54% in UCB ( p < 0.001). Graft-versus-host disease occurred in 51.7%, pulmonary complications in 32.8%, and neurological toxicity in 25.9%. Secondary malignancies were reported in four patients.

Conclusion

TBI-based conditioning achieved acceptable outcomes in PBSC recipients but was associated with markedly higher NRM in UCB recipients. These findings highlight graft source as a critical determinant of survival and support individualized strategies in allo-HSCT.

Schlagwörter

Stichwörter der Autor:innen

Acute lymphoblastic leukemiaAllo-HSCTPeripheral blood stem-cell transplantationTotal body irradiationUmbilical cord blood transplantation

Autor:innen und Institutionen

  • Department of Radiation Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain. Uriel.corro@estudiante.uam.es.
  • PhD program in Medicine and Surgery from Universidad Autónoma de Madrid, Madrid, Spain. Uriel.corro@estudiante.uam.es.
  • Department of Radiation Oncology, Hospital Universitario Marqués de Valdecilla-Santander, Cantabria, Spain. Uriel.corro@estudiante.uam.es.
  • Department of Radiation Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
  • Department of Radiation Oncology, Hospital Universitario Marqués de Valdecilla-Santander, Cantabria, Spain.
  • Department of Hematology and Hemotherapy, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.

Förderung

  • CRUE-CESIC
  • Universidad Autónoma de Madrid

Zitieren

APA

Corro Verde, U. A., Romero Fernández, J., Gil Haro, B., López Valcárcel, M., Sarrión Rubio De la Torre, P., Bautista, G., & De la Fuente Alonso, C. (2026). Total body irradiation-based conditioning in allogeneic transplantation in patients with hematological malignancies: impact in outcomes by stem-cell source. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-026-04523-1

Vancouver

Corro Verde UA, Romero Fernández J, Gil Haro B, López Valcárcel M, Sarrión Rubio De la Torre P, Bautista G, et al. Total body irradiation-based conditioning in allogeneic transplantation in patients with hematological malignancies: impact in outcomes by stem-cell source. Clinical and Translational Oncology. 2026. doi:10.1007/s12094-026-04523-1

BibTeX
@article{CorroVerde2026,
  author = {Corro Verde, Uriel Alexander and Romero Fernández, Jesús and Gil Haro, Beatriz and López Valcárcel, Marta and Sarrión Rubio De la Torre, Patricia and Bautista, Guiomar and De la Fuente Alonso, Cristina},
  title = {Total body irradiation-based conditioning in allogeneic transplantation in patients with hematological malignancies: impact in outcomes by stem-cell source},
  journal = {Clinical and Translational Oncology},
  year = {2026},
  doi = {10.1007/s12094-026-04523-1}
}
Kostenlos starten →